Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05908448 · ClinicalTrials.gov registry record
The True Vie I3 Continuous Glucose Monitoring System in Pediatric Patients With Type 1 Diabetes Mellitus
A clinical trial, sponsored by Sinocare.
- Completed
- Registry status
- 134
- Enrollment target
NCT05908448 is a clinical trial that has completed, run by Sinocare. The registered enrollment target is 134 participants.
The verdict
NCT05908448 has completed, sponsored by Sinocare.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The purpose of the investigation is to evaluate the performance of the I3 CGM in Pediatric Patients with Type 1 Diabetes Mellitus (T1DM) according to the FDA's special controls for iCGM.
Interventions
- DEVICE 13 CGM (continuous glucose monitor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2024-11-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05908448
The ClinicalTrials.gov registry entry for NCT05908448 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sinocare, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 13 CGM (continuous glucose monitor) is the first listed.
NCT05908448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05908448 about?
NCT05908448 is a clinical study titled "The True Vie I3 Continuous Glucose Monitoring System in Pediatric Patients With Type 1 Diabetes Mellitus". The purpose of the investigation is to evaluate the performance of the I3 CGM in Pediatric Patients with Type 1 Diabetes Mellitus (T1DM) according to the FDA's special controls for iCGM.
What is the current status of trial NCT05908448?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2024-02-07. Estimated completion is 2024-11-13.
What interventions are being tested in trial NCT05908448?
The interventions under investigation include: 13 CGM (continuous glucose monitor) (DEVICE).
Who is sponsoring clinical trial NCT05908448?
This trial is sponsored by Sinocare, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.